Evidence map›Paper›PMID 39843792›Full record

ArticleEuropean journal of pediatrics2025

Development and maintenance of consensus recommendations on pediatric outpatient antibiotic therapy in Germany: a framework for rational use.

Janina Soler Wenglein, Arne Simon, Reinhard Berner, Holger Brockmeyer, Johannes Forster, Eckard Hamelmann, Wolfgang Klein, Johannes Liese, Jennifer Neubert, Johannes Pfeil and 6 more

Abstract readConsensus Statement
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Janina Soler WengleinDepartment of Pediatrics, Protestant Hospital of the Bethel Foundation, Medical School and University Medical Center OWL, Bielefeld University, Bielefeld, Germany. janina.soler@uni-bielefeld.de.
Arne SimonPediatric Oncology and Hematology, Pediatric Infectious Diseases, Children's Hospital, Saarland University Medical Center, Homburg, Germany.
Reinhard BernerDepartment of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Holger BrockmeyerPraxis für Kinder und Jugendliche Holger Brockmeyer, Hamburg, Germany.
Johannes ForsterInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg, Germany.
Eckard HamelmannDepartment of Pediatrics, Protestant Hospital of the Bethel Foundation, Medical School and University Medical Center OWL, Bielefeld University, Bielefeld, Germany.
Wolfgang KleinPraxis für Kinder- und Jugendmedizin Wolfgang Klein, Augsburg, Germany.
Johannes LieseDepartment of Pediatrics, University Hospital Würzburg, Würzburg, Germany.
Jennifer NeubertPraxis für Kinder- und Jugendmedizin Jennifer Neubert, Neuss, Germany.
Johannes PfeilKinder- und Hausarztpraxis Johannes Pfeil, Schwaigern, Germany.
Hanna RenkDepartment of Pediatric Neurology and Developmental Medicine, University Children's Hospital, Tübingen, Germany.
Tobias TenenbaumChild and Adolescent Medicine, Sana Children's Hospital Lichtenberg, Academic Teaching Hospital Charité-Universitätsmedizin Berlin, Berlin, Germany.
Nicole ToepfnerDepartment of Pediatrics, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
further ABSaP Working Group members
Markus HufnagelDivision of Pediatric Infectious Diseases and Rheumatology, Department of Pediatrics and Adolescent Medicine, Medical Faculty, University Medical Centre, University of Freiburg, Freiburg, Germany.
Roland TillmannPraxis für Kinder- und Jugendmedizin Roland Tillmann, Ärztenetz Bielefeld, Bielefeld, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In pediatric outpatient care, overuse and misuse of antibiotics is linked to a high risk of adverse events and increased antibiotic resistance. In 2019, building upon the work of the Antibiotic Therapy in Bielefeld (AnTiB) project (founded in 2016), a collaboration among the AnTiB, the German Society for Pediatric Infectious Diseases (DGPI), and the Professional Association of Outpatient Pediatricians and Adolescent Physicians (BVKJ) was established to develop consensus recommendations for antibiotic therapy in pediatric outpatient settings in Germany. This working group became the Antibiotic Stewardship in Outpatient Pediatrics (ABSaP). ABSaP institutes recommendations for antibiotic use in outpatient pediatric settings in Germany and updates them regularly. The ABSaP guidelines recommend restrictive, targeted, evidence-based prescription practices for antibiotics used to treat common infections among pediatric outpatients. This expert-driven, pragmatic, best-practice guidance is designed to be a living document. ABSaP's most recent update was published in March 2024. The recommendations aim to guide and standardize rational antibiotics use by emphasizing the importance of avoiding unnecessary prescriptions, while also promoting the application of narrow-spectrum antibiotics, short-duration therapy, and watchful waiting, when treating mild, self-limiting infections in children without significant risk factors.

conclusionsABSaP's guidelines may provide a model for others, as well as offer a basis for discussing practical, effective antibiotic stewardship (ABS) measures in pediatric primary care. An international, expert consensus on ABS for pediatric outpatients could help promote a culture of responsible antibiotic use, improve prescribing safety, and contribute to broader ABS efforts. WHAT IS KNOWN: • Overuse and misuse of antibiotics are associated with adverse events and increased antibiotic resistance, prompting the need for effective antibiotic stewardship initiatives. • The Antibiotic Stewardship in Outpatient Pediatrics (ABSaP) working group was established to develop and regularly update evidence-based best practice recommendations for the targeted and restrictive use of antibiotics in pediatric outpatient settings in Germany. WHAT IS NEW: • The most recent update of the ABSaP guidelines was published in March 2024, emphasizing the importance of narrow-spectrum antibiotics, short-duration therapy, and watchful waiting for mild infections, aiming to standardize rational antibiotic use in children. • The ABSaP guidelines have become widely accepted in Germany and are now being translated into English to foster international dialogue and collaboration on antibiotic stewardship in pediatric primary care, potentially serving as a model for similar initiatives in other countries.

Indexed as

Ambulatory CareAnti-Bacterial AgentsAntimicrobial StewardshipPediatricsChildConsensusGermanyHumansInappropriate PrescribingPractice Guidelines as TopicAnti-Bacterial AgentsAntibiotic prescriptionAntibiotic stewardshipBest practicesOutpatient pediatricsStandard of care

Identifiers

PMID39843792
PMCPMC11754357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.